We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$789M
AUM Growth
-$76.5M
Cap. Flow
+$29.9M
Cap. Flow %
3.79%
Top 10 Hldgs %
27.06%
Holding
1,208
New
169
Increased
297
Reduced
314
Closed
91

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.36M
2
TSN icon
Tyson Foods
TSN
+$4.6M
3
BAC icon
Bank of America
BAC
+$4.41M
4
HAS icon
Hasbro
HAS
+$3.88M
5
USB icon
US Bancorp
USB
+$3.09M

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Healthcare 12.98%
3 Financials 11.5%
4 Consumer Staples 8.7%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBGI
1201
Digital Brands Group
DBGI
$9.36M
0
RMO
1202
DELISTED
Romeo Power, Inc.
RMO
$0 ﹤0.01%
440
+210
+91% +$197
SAIL
1203
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
-185
Closed -$9K
ATC
1204
DELISTED
Atotech Limited
ATC
-110
Closed -$2K
TVTY
1205
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-166
Closed -$5K
ZNGA
1206
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-1,050
Closed -$10K
AZPN
1207
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-19
Closed -$3K
AIM
1208
AIM ImmunoTech
AIM
$7.86M
-15
Closed -$2K

Similar funds

Howe & Rusling's Q2 2022 Portfolio in Review

As of Q2 2022, Howe & Rusling held 1,208 positions worth $789M, down 8.8% from $865M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling deployed $29.9M of net new capital in Q2 2022, opening 169 new positions and adding to 297 existing holdings. Its largest new stake was AstraZeneca: 35,197 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $9.36M trimmed.

  • Howe & Rusling's largest Q2 2022 buy was AstraZeneca: 35,197 shares worth $4.65M.
  • Howe & Rusling added most to Lowe's Companies in Q2 2022, an estimated $6.75M increase.
  • Howe & Rusling's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.36M.
  • Howe & Rusling fully exited Traeger in Q2 2022, selling an estimated $124K.
  • Howe & Rusling's ten largest holdings make up 27% of its $789M portfolio in Q2 2022.
  • Howe & Rusling opened 169 new positions and closed 91 in Q2 2022.
  • Howe & Rusling's portfolio value fell 8.8% quarter-over-quarter to $789M.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.